Skip to main content

Corporate insider profile

Steven Pieper Insider Trades

Latest reported as See Remarks of Xeris Biopharma Holdings, Inc. (XERS).

Purchase filings
0
Reported companies
1
Net open-market value
-$515,211.50
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale5,000$9.41$47,037
Sep 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale5,000$8.50$42,500
Aug 12, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale5,000$8.50$42,500
Jul 7, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale45,000$8.52$383,175